The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

avantium.com

Founded Year

2000

Stage

PIPE | IPO

Total Raised

$139.1M

Market Cap

0.14B

About Avantium Technologies

Avantium Technologies provides high-throughput R&D technologies for applications in the energy, chemicals and pharmaceutical industries.

Avantium Technologies Headquarter Location

Zekeringstraat 29

Amsterdam, 1014,

Netherlands

+31 (0)20 586 8080

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Avantium Technologies

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Avantium Technologies in 1 CB Insights research brief, most recently on Jan 24, 2022.

Expert Collections containing Avantium Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Avantium Technologies is included in 2 Expert Collections, including Advanced Materials.

A

Advanced Materials

1,253 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.

P

Packaging & Labeling Tech

534 items

Companies providing traditional and tech-enabled packaging and labeling solutions for brands.

Avantium Technologies Patents

Avantium Technologies has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/11/2013

1/16/2018

Fluid dynamics, Chemical reactions, Fluid mechanics, Valves, Chemical kinetics

Grant

Application Date

10/11/2013

Grant Date

1/16/2018

Title

Related Topics

Fluid dynamics, Chemical reactions, Fluid mechanics, Valves, Chemical kinetics

Status

Grant

Latest Avantium Technologies News

Global Polyethylene Furanoate Films Market Report 2020-2035 with Profiles of Avantium Technologies, Danone, The Coca-Cola Co, To...

Nov 23, 2020

News provided by Share this article The global polyethylene furanoate films market size is anticipated to reach USD 800.9 thousand by 2035., growing at a CAGR of 9.7% over the forecast period. The development of bio-based transparent conductive film comprised of silver nanowires for flexible optoelectronic devices is one of the key trends driving the demand for Polyethylene Furanoate (PEF) films. PEF films are better than PET films, in terms of performance, as they offer two to three times higher water vapor barrier, ten times higher oxygen barrier, and improved mechanical strength. The use of PEF films in food packaging extends the shelf life of moisture-sensitive foods, such as crisps, cookies, cereals, medical, and personal care products, and oxygen-sensitive foods, such as dairy products, fish, and meat, as well as provides a good barrier of aroma for detergents, fish, and packaged cheese. The extended shelf life of these products also lessens the burden on the cold chain industry. The biggest challenge faced by PEF film as a product is the lack of large-scale commercialization of the product. As the product is in the introduction phase and has a single pilot plant established, the requirement of infrastructure and operations is high considering the huge target market to be captured. This requires major funding and a possible partnership with packaging companies in the domestic markets as well as collaboration with domestic companies for the business development aspect, as done in Japan. Countries, such as Japan and India, recycle more than 80% of the plastics and buy PET at a relatively lower price, which does not make bioplastics a preferential option. This can be overcome if there are subsidiaries in place in respective countries that incentivize the use of bioplastics. Polyethylene Furanoate Films Market Report Highlights The market was valued at USD 197.5 thousand in 2019 and is estimated to grow at a CAGR of 9.7% from 2020 to 2035 The packaging was the largest application segment in 2019. Biaxially Oriented Polyethylene Furanoate (BOPEF) films-based pouches offer 10 times higher oxygen barrier compared to BOPET pouches, which makes them suitable for liquid and dry products Industrial application is estimated to emerge as the fastest-growing segment from 2020 to 2035 owing to increasing demand for PEF films in electronics application such as protective films for LED and OLED displays Asia Pacific accounted for the highest market share of more than 45% in 2019 and will expand further at a steady CAGR from 2020 to 2035 This growth is attributed to the rising demand for sustainable, bio-based, and recyclable packaging and construction materials in the region Key Topics Covered: Chapter 2 Executive Summary 3.1 Market Lineage Outlook 3.2 Penetration & Growth Prospect Mapping 3.3 Industry Value Chain Analysis 3.3.1 Raw Material Trends

Avantium Technologies Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Avantium Technologies Rank

  • When was Avantium Technologies founded?

    Avantium Technologies was founded in 2000.

  • Where is Avantium Technologies's headquarters?

    Avantium Technologies's headquarters is located at Zekeringstraat 29, Amsterdam.

  • What is Avantium Technologies's latest funding round?

    Avantium Technologies's latest funding round is PIPE.

  • How much did Avantium Technologies raise?

    Avantium Technologies raised a total of $139.1M.

  • Who are the investors of Avantium Technologies?

    Investors of Avantium Technologies include Aescap Venture, Capricorn Partners, ING Corporate Investments, Navitas Capital, Aster Capital and 19 more.

  • Who are Avantium Technologies's competitors?

    Competitors of Avantium Technologies include ThruPore Technologies, Austrianova, WuXi AppTec, CXR Biosciences, Veractect and 13 more.

You May Also Like

M
Micromyx

Micromyx is a microbiology services company engaged in anti-infective discovery and development for the pharmaceutical, biotechnology, and animal health industries. Founded in 2004 by former pharmaceutical industry infectious disease scientists, Micromyx is a contract research organization that aims to offer clients documented, top-of-the-line laboratory services from experts who have successfully gained FDA approval of new antibiotics.

Sai Life Sciences Logo
Sai Life Sciences

Sai Life Sciences offers their clients a wide range of integrated drug discovery, development and formulation services, with core expertise founded in synthetic, medicinal and process chemistry and further augmented by a suite of preclinical support services including DMPK, toxicology and formulation that are continually expanding to meet clients' needs.

C
Clinical Trials of the Americas

The company provide clinical research services to area physicians in a range of therapeutic specialties and contract with pharmaceutical companies and contract research organizations (CROs) to conduct in-patient clinical research. The company have successfully conducted more than 500 Phase I, II, III, and IV clinical trials and utilize the Clinasyst Software  System for trial management with a database of greater than 40,000 subjects.

P
Progenix Research

Progenix Research is an independent contract research organisation offering toxicology services to the world-wide pharmaceutical, biotechnology, agrochemical and industrial chemical industries. It is a newly formed, independent contract research organisation with laboratory facilities currently under construction in Penang, Malaysia. The company's European headquarters are based in Malvern, England, and it also has a histopathology laboratory in Edinburgh, Scotland. A high quality, yet cost-efficient service for toxicology and associated studies will be offered, including studies on pharmaceuticals, biotechnology products, medical devices, food additives, agrochemicals, biocides, and speciality chemicals.

Austrianova Logo
Austrianova

Austrianova is a biotech company based in Singapore embracing world quality standards for the production of cell-based products. The company's Quality System is German-made and data is stored in duplicate sites in Switzerland. The company's equipment is custom made by German and US manufacturers. Austrianova offers a full service for cell-based products from conception, cloning, through generation and characterisation of cell lines, to production of material for pre-clinical and GMP production for clinical trials.

inGenious Targeting Laboratory Logo
inGenious Targeting Laboratory

inGenious Targeting Laboratory (iTL) based in Stony Brook, New York was founded in 1998 and has continued to offer a suite of conventional mouse knockout , conditional mouse knockout, and mouse knockin services. The generation of conventional or conditional knockout mice, or knockin mice aims to utilize some gene targeting methodologies developed in iTL's mouse laboratories. Customers from numerous academic institutions, government institutions, and biotech / pharmaceutical companies worldwide have continued to count on iTL's transgenic mouse services.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.